News about Digitalization

Variant Bio Launches World's First Agentic AI Genomic Drug Discovery Platform

The agentic AI platform by Variant Bio, named Inference, brings together genetic and multi-omic data with autonomous analysis capabilities, and is already powering pharmaceutical partnerships totaling over USD 200 million.

Digitalization | 09/01/2026 | By News Bureau |  348

Sectra Enters Japan's Digital Pathology Market with Kameda Medical Centre Project

Sectra brings AI-enabled digital pathology workflows to Kameda Medical Centre in partnership with Matsunami Glass.

Digitalization | 07/01/2026 | By News Bureau |  355

Insilico Medicine and Servier Forge AI-Driven Oncology Drug Discovery Alliance

Insilico Medicine, a global leader in artificial intelligence–driven drug discovery, has entered into a multi-year research and development collaboration with Servier, an independent international pharmaceutical company governed by a foundation.

Digitalization | 06/01/2026 | By Darshana |  107

Revvity Launches AI Platform for Molecular and Materials Discovery

Revvity has launched a new AI-powered Models-as-a-Service (MaaS) platform designed to integrate in-silico molecular and materials design with experimental data, enabling continuous learning, improved predictive accuracy, and faster scientific discovery.

Digitalization | 17/12/2025 | By News Bureau |  166

Merck Launches ChemiSphere App to Streamline Digital Data Access and Enhance Lab Efficiency

Merck has launched the ChemiSphere app to streamline digital data access and improve lab efficiency by linking physical products with secure digital workflows, enabling quick access to key documentation such as SDS and CoA.

Digitalization | 17/12/2025 | By News Bureau |  226

Xcell Biosciences and Culture Biosciences Partner to Improve Cell Therapy Quality with AI and ML

Xcell Biosciences has partnered with Culture Biosciences to integrate AI- and ML-driven analytics into cell therapy development. The collaboration leverages a cloud-based platform capable of multivariate analysis, enabling real-time optimisation to enhance cell therapy performance and improve patient outcomes.

Digitalization | 10/12/2025 | By Akanki |  202

FDA Qualifies PathAI's AIM-MASH as First AI Tool for MASH Clinical Trials

PathAI has achieved a regulatory milestone with the FDA qualifying its AIM-MASH AI Assist as the first AI-powered tool for MASH clinical trials. The qualification follows the EMA CHMP’s endorsement earlier this year, reinforcing PathAI’s leadership in advancing AI-driven histopathology solutions across American and European drug-development framework.

Digitalization | 10/12/2025 | By Akanki |  1076

SmartWinnr Launches Medical Simulation to Advance AI Readiness in Pharma and Medtech

SmartWinnr has introduced a new medical simulation platform designed to help pharma and medtech companies accelerate AI readiness. Developed in collaboration with life sciences leaders and AI experts, the solution delivers clinically accurate, compliant, and emotionally intelligent training simulations for healthcare professionals.

Digitalization | 03/12/2025 | By Akanki |  248

Verida: Philips unveils first AI-driven detector-based spectral CT

The new platform integrates AI across the entire imaging chain—from acquisition to reconstruction—to reduce system noise, enhance image clarity, and significantly accelerate clinical workflows.

Digitalization | 02/12/2025 | By Darshana |  326

Generate:Biomedicines to Begin Phase 3 Trials of AI-Engineered Asthma Antibody GB-0895

Generate:Biomedicines is set to begin its first global Phase 3 trials for GB-0895, an AI-engineered long-acting anti-TSLP antibody for patients with severe, uncontrolled asthma. The SOLAIRIA-1 and SOLAIRIA-2 studies will evaluate the therapy in about 1,600 patients, marking a key milestone for programmable biology in respiratory care.

Digitalization | 02/12/2025 | By Dineshwori |  302